Clinical, Molecular and Metabolic Characteristics of Parkinson's Disease (PD) Patients With Parkin Mutation
Study Details
Study Description
Brief Summary
Parkinson's disease is a frequent neurodegenerative disorder. Genetic forms of the disease have been recently identified. The monogenic form due to parkin mutation is responsible for many familial cases and sporadic forms. However, the relationship between the mutation and the genotype of patients is not fully established. The aim of this study is to compare clinical, metabolic and neuropsychological characteristics obtained in patients with parkin mutation with those of patients without parkin mutation.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Outcome Measures
Primary Outcome Measures
- Parkin mutation []
- Motor disability []
- Neuropsychological evaluation []
- Psychiatric evaluation []
Secondary Outcome Measures
- Positron emission tomography []
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Juvenile Parkinson's disease (< 45 years)
-
Parkin mutation
-
Normal brain magnetic resonance imaging (MRI)
Exclusion Criteria:
-
Contraindication to brain MRI
-
Women without effective contraception
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Centre d'Investigation Clinique-Hôpital Pitié-Salpetriere | Paris | France |
Sponsors and Collaborators
- Groupe Hospitalier Pitie-Salpetriere
- University Hospital, Tours
Investigators
- Study Director: Alexis Brice, MD, PhD, Groupe Hospitalier Pitié-Salpêtrière
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- P011104